Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.

Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion of a large-scale data generation project producing comprehensive ...

Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI).

Clear Labs, a leader in fully automated next-generation sequencing (NGS) solutions, today announced the introduction of a new automated workflow featuring Pillar Biosciences' SLIMamp® chemistry on the ...

Dr. Joanne Mason discusses how Yourgene Health is advancing technologies that support long-read sequencing, reproductive ...

As global participation in digital-asset ecosystems expands and blockchain behaviour becomes increasingly complex, platforms ...

The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01 billion in 2025 and is projected to advance ...

There have been no truly new treatments for schizophrenia, bipolar disorder or psychosis for more than 50 years.

The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01 billion in 2025 and is projected to advance at a resilient ...

Kate Middleton and Prince William returned to public view together on Remembrance Sunday, November 9, 2025, marking their ...

Delaying STEAM education and learning until later grades means we risk leaving behind countless children and narrowing the ...